Prevalence of metabolic syndrome in bipolar disorder: An exploratory study from North India

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 141-146

  Grover, Sandeep ^a   Aggarwal, Munish ^a   Chakrabarti, Subho ^a   Dutt, Alakananda ^a   Avasthi, Ajit ^a   Kulhara, Parmanand ^a   Malhotra, Nidhi ^a   Somaiya, Mansi ^a   Chauhan, Nidhi ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bipolar disorder; India; Metabolic syndrome; Prevalence

Indexed keywords

TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; BODY MASS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPLORATORY RESEARCH; FEMALE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INDIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 82555176499     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.10.013     Document Type: Article

References (42)

1. Basu R., Brar J.S., Chengappa K.N., John V., Parepally H., Gershon S., et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder-bipolar subtype. Bipolar Disord 2004, 6(4):314-318.
2. Birkenaes A.B., Sogaard A.J., Engh J.A., Jonsdottir H., Ringen P.A., Vaskinn A., et al. Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population. J Clin Psychiatry 2006, 67(3):425-433.
3. Bond D.J., Kauer-Sant'Anna M., Lam R.W., Yatham L.N. Weight gain, obesity, and metabolic indices following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM). J Affect Disord 2010, 124(1-2):108-117.
4. Bowden D.W., Rudoc M., Ziegler J., Lehtinen A.B., Xu J., Wagenknecht L.E., et al. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006, 55(7):1985-1994.
5. Cardenas J., Frye M.A., Marusak S.L., Levander E.M., Chirichigno J.W., Lewis S., et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106(1-2):91-97.
6. Cate Carter T.D., Mundo E., Parikh S.V., Kennedy J.L. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003, 37(4):297-303.
7. Chang H.H., Chou C.H., Chen P.S., Gean P.W., Huang H.C., Lin C.Y., et al. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 2009, 117(1-2):124-129.
8. Chang H.H., Yang Y.K., Gean P.W., Huang H.C., Chen P.S., Lu R.B. The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord 2010, 124(3):319-323.
9. Chokka P., Tancer M., Yeragani V.K. Metabolic syndrome: relevance to antidepressant treatment. J Psychiatry Neurosci 2006, 31(6):414.
10. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics. Bipolar Disord 2008, 10(7):788-797.
11. D'Mello D.A., Narang S., Agredano G. Prevalence and consequences of metabolic syndrome in bipolar disorder. Psychiatr Times 2007, 24:1.
12. Elmslie J.L., Porter R.J., Joyce P.R., Hunt P.J., Shand B.I., Scott R.S. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Aust N Z J Psychiatry 2009, 43(1):53-60.
13. Fagiolini A., Frank E., Scott J.A., Turkin S., Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005, 7(5):424-430.
14. Fagiolini A., Chengappa K.N., Soreca I., Chang J. Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS Drugs 2008, 22(8):655-669.
15. Fiedorowicz J.G., Palagummi N.M., Forman-Hoffman V.L., Miller D.D., Haynes W.G. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008, 20(3):131-137.
16. Garcia-Portilla M.P., Saiz P.A., Benabarre A., Sierra P., Perez J., Rodriguez A., et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008, 106(1-2):197-201.
17. Garcia-Portilla M.P., Saiz P.A., Bascaran M.T., Martínez S., Benabarre A., Sierra P., et al. Cardiovascular risk in patients with bipolar disorder. J Affect Disord 2009, 115(3):302-308.
18. Grover S., Nebhinani N., Chakrabarti S., Avasthi A., Kulhara P. Metabolic syndrome among patients receiving clozapine: a preliminary estimate. Ind J Pharmacol 2011, 43(5):591-595.
19. Guerreiro D.F., Navarro R., Telles-Correia D., Martins P., Trigo E., Silva M. Effectivity of screening, concepts and attitudes towards metabolic syndrome: a study in bipolar patients followed in hospital Santa Maria psychiatric consultation. Acta Med Port 2010, 23(2):173-182.
20. John A.P., Koloth R., Dragovic M., Lim S.C. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust 2009, 190(4):176-179.
21. Kemp D.E., Calabrese J.R., Tran Q.V., Pikalov A., Eudicone J.M., Baker R.A. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder. J Clin Psychiatry 2010, 71(9):1138-1144.
22. Khatana S.A.M., Kane J., Taveira T.H., Bauer M.S., Wu W.-C. Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. PLoS One 2011, 6:e19298. 10.1371/journal.pone.0019298.
23. Kim B., Kim S., McIntyre R.S., Park H.J., Kim S.Y., Joo Y.H. Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment. Psychiatry Invest 2009, 6:78-84.
24. Lee N.Y., Kim S.H., Cho B., Lee Y.J., Chang J.S., Kan U.G. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34(7):1243-1249.
25. Maina G., D'Ambrosio V., Aguglia A., Paschetta E., Salvi V., Bogetto F. Bipolar disorders and metabolic syndrome: a clinical study in 185 patients. Riv Psichiatr 2010, 45(1):34-40.
26. McIntyre R.S., Danilewitz M., Liauw S.S., Kemp D.E., Nguyen T.T., Kahn L.S., et al. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord 2010, 126(3):366-387.
27. Padmawati R., McCreadle R.G., Tirupati S. Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia. Schizophr Res 2010, 121(1-3):199-202.
28. Perez-Jimenez F., Mora-Navarro G., Diez-Espino J. Epidemiologia. Impacto del síndrome metabolico en la salud publica en España. Med Clin Monograf (Barc) 2006, 7:8-12.
29. Pyykkonen A.J., Räikkönen K., Tuomi T., Eriksson J.G., Groop L., Isomaa B. Association between depressive symptoms and metabolic syndrome is not explained by antidepressant medication: results from the PPP-Botnia Study. Ann Med 2011, Jan 24. [Epub ahead of print].
30. Ravikiran M., Bhansali A., Ravi Kumar P., Bhansali S., Dutta P., Thakur J.S., et al. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract 2010, 89(2):181-188.
31. Sahoo S., Ameen S., Akhtar S. Incidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six week prospective study in Indian female patients. Schizophr Res 2007, 95(1-3):247.
32. Sahoo S., Manjunatha N., Ameen S., Akhtar S. Diabetes and schizophrenia-effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia. Acta Psychiatr Scand 2008, 117(5):342-347.
33. Sahoo S., Narayana M., Shahul A., Sayeed A. Metabolic syndrome in first episode schizophrenia: a randomized double-blind controlled, short-term prospective study. Schizophr Res 2008, 101(1-3):266-272.
34. Salvi V., Albert U., Chiarle A., Soreca I., Bogetto F., Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 2008, 30(4):318-323.
35. Sicras A., Rejas J., Navarro R., Serrat J., Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008, 10(5):607-616.
36. Taylor V., Macqueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 2006, 67(7):1034-1041.
37. Teixeira P.J., Rocha F.L. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007, 29(4):330-336.
38. van Winkel R., De Hert A., Van Eyck D., Hanssens L., Wampers M., Scheen A., et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008, 10(2):342-348.
39. van Winkel R., Van O.J., Celic I., Van E.D., Wampers M., Scheen A., et al. Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. J Clin Psychiatry 2008, 69(8):1319-1327.
40. Vuksan-Cusa B., Marcinko D., Nad S., Jakovljevic M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33(1):109-112.
41. Vuksan-Cusa B., Jakovljevic M., Sagud M., Peles A.M., Marcinko D., Topic R., et al. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and Schizophrenia treated with SGA. Psychiatry Res 2011, 10.1016/j.psychres.2010.11.021.
42. Yumru M., Savas H.A., Kurt E., Kaya M.C., Selek S., Savas E., et al. Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord 2007, 98(3):247-252.